These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 18722127

  • 1. Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy.
    Sriram M, Hall JJ, Grohmann NC, Strecker TE, Wootton T, Franken A, Trawick ML, Pinney KG.
    Bioorg Med Chem; 2008 Sep 01; 16(17):8161-71. PubMed ID: 18722127
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
    Devkota L, Lin CM, Strecker TE, Wang Y, Tidmore JK, Chen Z, Guddneppanavar R, Jelinek CJ, Lopez R, Liu L, Hamel E, Mason RP, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem; 2016 Mar 01; 24(5):938-956. PubMed ID: 26852340
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents.
    Tanpure RP, George CS, Strecker TE, Devkota L, Tidmore JK, Lin CM, Herdman CA, Macdonough MT, Sriram M, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem; 2013 Dec 15; 21(24):8019-32. PubMed ID: 24183586
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of 3-(trimethoxyphenyl)-2(3H)-thiazole thiones as combretastatin analogs.
    Banimustafa M, Kheirollahi A, Safavi M, Kabudanian Ardestani S, Aryapour H, Foroumadi A, Emami S.
    Eur J Med Chem; 2013 Dec 15; 70():692-702. PubMed ID: 24219991
    [Abstract] [Full Text] [Related]

  • 5. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
    Sharma S, Gupta MK, Saxena AK, Bedi PM.
    Anticancer Agents Med Chem; 2017 Dec 15; 17(2):230-240. PubMed ID: 27141882
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
    Mustafa M, Abdelhamid D, Abdelhafez EMN, Ibrahim MAA, Gamal-Eldeen AM, Aly OM.
    Eur J Med Chem; 2017 Dec 01; 141():293-305. PubMed ID: 29031074
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and biological evaluation of arylcinnamide linked combretastatin-A4 hybrids as tubulin polymerization inhibitors and apoptosis inducing agents.
    Kamal A, Bajee S, Lakshma Nayak V, Venkata Subba Rao A, Nagaraju B, Ratna Reddy C, Jeevak Sopanrao K, Alarifi A.
    Bioorg Med Chem Lett; 2016 Jun 15; 26(12):2957-2964. PubMed ID: 27161282
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
    Hu Y, Lu X, Chen K, Yan R, Li QS, Zhu HL.
    Bioorg Med Chem; 2012 Jan 15; 20(2):903-9. PubMed ID: 22192936
    [Abstract] [Full Text] [Related]

  • 13. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.
    Ducki S, Rennison D, Woo M, Kendall A, Chabert JF, McGown AT, Lawrence NJ.
    Bioorg Med Chem; 2009 Nov 15; 17(22):7698-710. PubMed ID: 19837593
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of pyrimidine bridged combretastatin derivatives as potential anticancer agents and mechanistic studies.
    Kumar B, Sharma P, Gupta VP, Khullar M, Singh S, Dogra N, Kumar V.
    Bioorg Chem; 2018 Aug 15; 78():130-140. PubMed ID: 29554587
    [Abstract] [Full Text] [Related]

  • 16. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
    Medarde M, Maya AB, Pérez-Melero C.
    J Enzyme Inhib Med Chem; 2004 Dec 15; 19(6):521-40. PubMed ID: 15662956
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
    Pirali T, Busacca S, Beltrami L, Imovilli D, Pagliai F, Miglio G, Massarotti A, Verotta L, Tron GC, Sorba G, Genazzani AA.
    J Med Chem; 2006 Aug 24; 49(17):5372-6. PubMed ID: 16913727
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.
    Monk KA, Siles R, Hadimani MB, Mugabe BE, Ackley JF, Studerus SW, Edvardsen K, Trawick ML, Garner CM, Rhodes MR, Pettit GR, Pinney KG.
    Bioorg Med Chem; 2006 May 01; 14(9):3231-44. PubMed ID: 16442292
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers.
    Kamal A, Shaik B, Nayak VL, Nagaraju B, Kapure JS, Shaheer Malik M, Shaik TB, Prasad B.
    Bioorg Med Chem; 2014 Oct 01; 22(19):5155-67. PubMed ID: 25192811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.